Literature DB >> 7528012

Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.

N K Rushmere1, R A Harrison, C W van den Berg, B P Morgan.   

Abstract

We have previously described the purification and partial characterization of the rat analogue of the human complement regulatory molecule CD59 [Hughes, Piddlesden, Williams, Harrison and Morgan (1992) Biochem. J. 284, 169-176]. We present here the molecular cloning and full sequence analysis of this molecule. A PCR-based approach utilizing primers designed from the amino-terminal protein sequence was used to isolate a full-length cDNA clone from a rat kidney cDNA library. This clone encoded a 92 bp 5'-flanking sequence, a 66 bp signal peptide and a 315 bp coding region containing putative glycosylation and GPI-anchor signals. The 3' untranslated flanking region was approximately 1.1 kbp long and included the poly-A tail and a CATA repeating sequence. The coding region was 58% identical with the human cDNA at the nucleotide level and 44% identical at the amino acid level. Despite this relatively low overall sequence conservation, several highly conserved stretches were apparent, particularly in the N-terminal portion of the molecule, in the cysteine-rich region immediately preceding the site of glycolipid attachment and in the C-terminal peptide removed during glycolipid attachment. An N-glycosylation site was identified at Asn-16 and a putative glycosylphosphatidylinositol anchor addition site at Asn-79, indicating that the mature processed protein was two residues longer than human CD59. Comparison of the sequences of rat and human CD59, together with consideration of the published three-dimensional structure of human CD59 and functional data, implicates specific regions of the protein in interactions with C-8 and/or C-9.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528012      PMCID: PMC1137533          DOI: 10.1042/bj3040595

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  34 in total

1.  Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.

Authors:  S J Piddlesden; B P Morgan
Journal:  J Neuroimmunol       Date:  1993 Nov-Dec       Impact factor: 3.478

2.  Characterization of two novel Ly-6 genes. Protein sequence and potential structural similarity to alpha-bungarotoxin and other neurotoxins.

Authors:  T J Fleming; C O'hUigin; T R Malek
Journal:  J Immunol       Date:  1993-06-15       Impact factor: 5.422

Review 3.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

4.  The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.

Authors:  C W van den Berg; R A Harrison; B P Morgan
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Determination of carboxyl-terminal residue and disulfide bonds of MACIF (CD59), a glycosyl-phosphatidylinositol-anchored membrane protein.

Authors:  Y Sugita; Y Nakano; E Oda; K Noda; T Tobe; N H Miura; M Tomita
Journal:  J Biochem       Date:  1993-10       Impact factor: 3.387

6.  Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells.

Authors:  T R Hughes; S Meri; M Davies; J D Williams; B P Morgan
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

7.  Sequence-specific 1H-NMR assignments and folding topology of human CD59.

Authors:  C M Fletcher; R A Harrison; P J Lachmann; D Neuhaus
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

8.  Tissue distribution of complement regulatory membrane proteins in rats.

Authors:  K Funabashi; N Okada; S Matsuo; T Yamamoto; B P Morgan; H Okada
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

9.  Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted.

Authors:  C W van den Berg; B P Morgan
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

10.  Presence of a dysfunctional form of CD59 on a CD59+ subclone of the U937 cell line.

Authors:  C W van den Berg; O M Williams; B P Morgan
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

View more
  14 in total

Review 1.  Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.

Authors:  A L Bothwell
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Production and functional analysis of rat CD59 and chimeric CD59-Crry as active soluble proteins in Pichia pastoris.

Authors:  R J Quigg; C He; B K Hack; J J Alexander; B P Morgan
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

3.  Binding of human and rat CD59 to the terminal complement complexes.

Authors:  T Lehto; B P Morgan; S Meri
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.

Authors:  J Yu; T Caragine; S Chen; B P Morgan; A B Frey; S Tomlinson
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

5.  Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function.

Authors:  N K Rushmere; S Tomlinson; B P Morgan
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

6.  Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59.

Authors:  D L Bodian; S J Davis; B P Morgan; N K Rushmere
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

7.  Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.

Authors:  Claire L Harris; S Melanie Hanna; Masashi Mizuno; Dewi S Holt; Kevin J Marchbank; B Paul Morgan
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

8.  Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis.

Authors:  S Meri; T Lehto; C W Sutton; J Tyynelä; M Baumann
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

9.  Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

Authors:  C L Harris; A S Williams; S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.

Authors:  A Nomura; K Nishikawa; Y Yuzawa; H Okada; N Okada; B P Morgan; S J Piddlesden; M Nadai; T Hasegawa; S Matsuo
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.